David McMillan

Years Active: 2019-2023
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Gareth C G Davies, Neesha Dedi, Paul S Jones, Lara Kevorkian, David McMillan, Cristina Ottone, Monika-Sarah E D Schulze, Anthony Scott-Tucker, Roohi Tewari, Shauna West, Michael Wright, Tania F Rowley
Discovery of ginisortamab, a potent and novel anti-gremlin-1 antibody in clinical development for the treatment of cancer. mAbs 15 (1) (2023)
David McMillan, Carlos Martinez-Fleites, John Porter, David Fox, Rachel Davis, Prashant Mori, Tom Ceska, Bruce Carrington, Alastair Lawson, Tim Bourne, James O'Connell
Structural insights into the disruption of TNF-TNFR1 signalling by small molecules stabilising a distorted TNF. Nature communications 12 (1) (2021)
James O'Connell, John Porter, Boris Kroeplien, Tim Norman, Stephen Rapecki, Rachel Davis, David McMillan, Tracy Arakaki, Alex Burgin, David Fox Iii, Tom Ceska, Fabien Lecomte, Alison Maloney, Alex Vugler, Bruce Carrington, Benjamin P Cossins, Tim Bourne, Alastair Lawson
Small molecules that inhibit TNF signalling by stabilising an asymmetric form of the trimer. Nature communications 10 (1) (2019)

David McMillan.css-eqlu8i{font-size:small;padding-left:4px;}